Integrative transcriptomic and proteomic profile revealed inhibition of oxidative phosphorylation and peroxisomes

Cheng Wang1, Zhuo Pan2, Linxiao Sun3

  • 1Department of Laboratory, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, PR China.

Journal of Proteomics
|March 2, 2024
PubMed

Insights

This study integrates transcriptomic and proteomic data to uncover chronic kidney disease (CKD) mechanisms. We found repressed reactive oxygen species (ROS) metabolism and antioxidant systems, offering new insights for CKD therapies.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genomics and Proteomics

Background:

  • Chronic kidney disease (CKD) lacks effective therapies due to unclear molecular pathogenesis.
  • Previous single-omics studies provided incomplete insights into CKD molecular regulation.
  • There is an urgent need for novel biomarkers and therapeutic strategies for CKD.

Purpose of the Study:

  • To perform an integrated transcriptomic and proteomic analysis of CKD.
  • To gain deeper insights into the continuous transcription-translation process in CKD.
  • To identify molecular mechanisms underlying CKD pathogenesis.

Main Methods:

  • Generated integrated transcriptomic and proteomic profiles from a UUO mouse model.
  • Identified 14,948 transcripts and 6423 proteins.
  • Performed combined bioinformatics analysis on common differentially expressed genes.

Main Results:

  • Revealed significantly repressed reactive oxygen species (ROS) metabolism in CKD.
  • Identified an imbalanced antioxidant system involving mitochondria and peroxisomes.
  • Selected 233 up-regulated and 364 down-regulated common differentially expressed genes.

Conclusions:

  • This multi-omics analysis sheds light on CKD molecular mechanisms.
  • The findings provide a basis for understanding CKD pathogenesis.
  • This study supports the development of future CKD management and drug discovery.

Related Concept Videos